WCN

Research on Using Fluid Biomarkers to Advance Drug Treatments and Therapies for Alzheimer's, Traumatic Brain Injury, Concussion, and Other Neurodegenerative Diseases Presented at World Congress of Neurology 2021 by Neuroscientist Henrik Zetterberg

Retrieved on: 
Thursday, October 7, 2021
Blood, Neurochemistry, Cerebrospinal fluid, Clinical trial, Neurodegeneration, Astrocyte, Neurological disorder, Diagnosis, World Federation of Neurology, Interview, Congress, World government, Concussion, Stroke, Patient, University of Gothenburg, Physician, Alzheimer's disease, Health, Biomarker, Twitter, WCN, University, Communication, Brain, TBI, Disease, Society, SIN, Research, Fluid mechanics, WFN, Tissue, Association, Organization, Data analysis, Traumatic brain injury, Neuron, Medical imaging, Pharmaceutical industry

For many years, easy clinical tests to find biomarkers in cerebrospinal fluid, a water-like substance that surrounds the brain and bathes the neurons, have not existed for the brain.

Key Points: 
  • For many years, easy clinical tests to find biomarkers in cerebrospinal fluid, a water-like substance that surrounds the brain and bathes the neurons, have not existed for the brain.
  • Only through a lumbar puncture, a painful and somewhat difficult procedure, could brain biomarkers be detected.
  • WFN supports the spread of research and clinical information in the pursuit of improvements in the field of neurology.
  • With support from member organizations around the globe, WFN unites the world to allow patients greater access to brain health.

New, Unpublished Data Reveals Impact of COVID-19 in Patients With Neurological Disorders; Renowned Neuroscientist Ettore Beghi Presents Findings in "Special Lecture on Neuro COVID," Oct 4, 2021, World Congress of Neurology 2021

Retrieved on: 
Tuesday, October 5, 2021
Guillain–Barré syndrome, Neurological disorder, Neurodegeneration, World Federation of Neurology, Congress, European Academy of Neurology, Even and odd functions, World government, Stroke, Hospital, National, Dysexecutive syndrome, Patient, Peripheral neuropathy, University of Bern, University of Milan, Hypertension, Twitter, WCN, COVID, Death, University, Cardiovascular disease, Government budget balance, University of Innsbruck, Risk, Society, COVID-19, Grenoble Alpes University, Peripheral nervous system, SIN, Research, Association, Data, WFN, Brain, History, Organization, Time, United Kingdom, Registry, Lists of diseases, Pharmaceutical industry

Beghi's presentation, "Special Lecture on Neuro COVID," detailed both published and newly released findings of the European Academy of Neurology COVID-19 Registry (ENERGY), of which Beghi is a member.

Key Points: 
  • Beghi's presentation, "Special Lecture on Neuro COVID," detailed both published and newly released findings of the European Academy of Neurology COVID-19 Registry (ENERGY), of which Beghi is a member.
  • "COVID-19 worsens patients' functional abilities, putting them at a greater risk of premature mortality, prolonged hospitalization and persistingneurological symptoms during follow-up," he added.
  • Data also reveals that patients with neurodegenerative diseases tend to have more severe COVID cases and worse outcomes than those who do not.
  • With support from member organizations around the globe, WFN unites the world to allow patients greater access to brain health.

New, Unpublished Data Reveals Impact of COVID-19 in Patients With Neurological Disorders; Renowned Neuroscientist Ettore Beghi Presents Findings in "Special Lecture on Neuro COVID," Oct 4, 2021, World Congress of Neurology 2021

Retrieved on: 
Tuesday, October 5, 2021
Guillain–Barré syndrome, Neurological disorder, Neurodegeneration, World Federation of Neurology, Congress, European Academy of Neurology, Even and odd functions, World government, Stroke, Hospital, National, Dysexecutive syndrome, Patient, Peripheral neuropathy, University of Bern, University of Milan, Hypertension, Twitter, WCN, COVID, Death, University, Cardiovascular disease, Government budget balance, University of Innsbruck, Risk, Society, COVID-19, Grenoble Alpes University, Peripheral nervous system, SIN, Research, Association, Data, WFN, Brain, History, Organization, Time, United Kingdom, Registry, Lists of diseases, Pharmaceutical industry

Beghi's presentation, "Special Lecture on Neuro COVID," detailed both published and newly released findings of the European Academy of Neurology COVID-19 Registry (ENERGY), of which Beghi is a member.

Key Points: 
  • Beghi's presentation, "Special Lecture on Neuro COVID," detailed both published and newly released findings of the European Academy of Neurology COVID-19 Registry (ENERGY), of which Beghi is a member.
  • "COVID-19 worsens patients' functional abilities, putting them at a greater risk of premature mortality, prolonged hospitalization and persistingneurological symptoms during follow-up," he added.
  • Data also reveals that patients with neurodegenerative diseases tend to have more severe COVID cases and worse outcomes than those who do not.
  • With support from member organizations around the globe, WFN unites the world to allow patients greater access to brain health.

Scholar Rock to Present Apitegromab TOPAZ Phase 2 Pharmacologic Data at the 2021 World Congress of Neurology

Retrieved on: 
Sunday, October 3, 2021
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Gongshi, Food, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Spinal muscular atrophy, Clinical trial, ODD, SMA, Serum, Myostatin, Motor neuron, Muscle weakness, SMN, Rock, Risk, Congress, Security (finance), Therapy, European Medicines Agency, Private Securities Litigation Reform Act, NASDAQ, U.S. Securities and Exchange Commission, FDA, Cancer, Fast Track, Patient, Pathology, LinkedIn, RPD, Gene, Genetic disorder, WCN, Investor, Company, Growth, COVID-19, SMN2, Human, SMN1, TOPAZ, Atrophy, FTD, Safety, Survival, Fibrosis, Orphan drug, EMA, Neuromuscular Disorders, Pharmaceutical industry, Apitegromab, SMA, Scholar Rock, APITEGROMAB, SMA, SCHOLAR ROCK

Time: Virtual e-posters are available for viewing for the duration of the congress (October 3-7, 2021) and will be available on demand for 3 months post conference.

Key Points: 
  • Time: Virtual e-posters are available for viewing for the duration of the congress (October 3-7, 2021) and will be available on demand for 3 months post conference.
  • Apitegromab is a selective inhibitor of the activation of myostatin and is an investigational product candidate for the treatment of patients with spinal muscular atrophy (SMA).
  • Scholar Rock believes that inhibiting myostatin activation with apitegromab may promote a clinically meaningful improvement in motor function in patients with SMA.
  • Scholar Rock believes its focus on biologically validated growth factors may facilitate a more efficient development path.

Teva to Present 8 Abstracts on AJOVY® (fremanezumab-vfrm) Injection and Hold Symposium on Healthcare Disparities at WCN

Retrieved on: 
Thursday, September 30, 2021
Biotechnology, General Health, Pharmaceutical, Health, Contraindication, TEVA, Angioedema, Healthcare disparity in Massachusetts, Veni, vidi, vici, Review, Compliance, Failure, 2021 Essex County Council election, Progress, Annual report, Anaphylaxis, Congress, Hypersensitivity, Private Securities Litigation Reform Act, Excipient, Patient, Drug, MD, Teva, Industry, Itch, Disability, WCN, Knowledge, TASE, Mab, Geography, Awareness, Rash, Hives, Migraine, COVID-19, Health care, Forward-looking statement, Safety, Investment, Quality of life, Literature, NYSE, Headache, OLE, Travel, Pharmaceutical industry, Medical device, Vaccine

Addressing healthcare disparities within migraine treatment is a key area of focus.

Key Points: 
  • Addressing healthcare disparities within migraine treatment is a key area of focus.
  • The full set of abstracts approved by the congress scientific committee and sponsored by Teva include:
    Adverse events should be reported.
  • Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve peoples lives for more than a century.
  • Factors associated with, and mitigation strategies for, healthcare disparities faced by patients with headache disorders.

Waste Connections Announces Dates For Third Quarter 2021 Earnings Release And Upcoming Management Presentation

Retrieved on: 
Wednesday, September 22, 2021
Waste Connections, Pacific Northwest, News, WCN, Company, Movement, Recycling, Municipal solid waste

TORONTO, Sept. 22, 2021 /PRNewswire/ -- Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") today announced that it will report financial results for the third quarter of 2021 after the close of the stock market on October 27, 2021.

Key Points: 
  • TORONTO, Sept. 22, 2021 /PRNewswire/ -- Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") today announced that it will report financial results for the third quarter of 2021 after the close of the stock market on October 27, 2021.
  • The Company will be hosting an investor conference call related to this release on October 28th at 8:30 A.M. Eastern Time.
  • A live audio webcast of the conference call can be accessed by visiting investors.wasteconnections.com and selecting "News & Events" from the website menu.
  • For more information, visit Waste Connections at www.wasteconnections.com .

Waste Connections Announces Repayment Of Senior Notes

Retrieved on: 
Monday, September 20, 2021
Debt-to-GDP ratio, Risk, PSLRA, Pacific Northwest, Private Securities Litigation Reform Act, WCN, Waste Connections, Company, Terminology, Growth, Forward-looking statement, Movement, Recycling, SEC, Municipal solid waste, Bank, Security (finance)

TORONTO, Sept. 20, 2021 /PRNewswire/ -- Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") today announcedthe repayment of all of its outstanding senior notes under its master note purchase agreements (the "Notes") with an aggregate principal amount of $1.500 billion and maturities ranging from 2022 through 2027.

Key Points: 
  • TORONTO, Sept. 20, 2021 /PRNewswire/ -- Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") today announcedthe repayment of all of its outstanding senior notes under its master note purchase agreements (the "Notes") with an aggregate principal amount of $1.500 billion and maturities ranging from 2022 through 2027.
  • Waste Connections is an integrated solid waste services company that provides non-hazardous waste collection, transfer and disposal services, along with resource recovery primarily through recycling and renewable fuels generation.
  • Waste Connections also provides non-hazardous oilfield waste treatment, recovery and disposal services in several basins across the U.S., as well as intermodal services for the movement of cargo and solid waste containers in the Pacific Northwest.
  • These forward-looking statements are neither historical facts nor assurances of future performance and reflect Waste Connections' current beliefs and expectations regarding future events and operating performance.

Waste Connections Announces Pricing Of $1.5 Billion Of Senior Notes

Retrieved on: 
Tuesday, September 7, 2021

BofA Securities, J.P. Morgan, MUFG and Wells Fargo Securities are acting as joint book-running managers and underwriters for the Offering.

Key Points: 
  • BofA Securities, J.P. Morgan, MUFG and Wells Fargo Securities are acting as joint book-running managers and underwriters for the Offering.
  • Waste Connections is an integrated solid waste services company that provides non-hazardous waste collection, transfer and disposal services, along with resource recoveryprimarily through recycling and renewable fuels generation.
  • Waste Connections also provides non-hazardous oilfield waste treatment, recovery and disposal services in several basins across the U.S., as well as intermodal services for the movement of cargo and solid waste containers in the Pacific Northwest.
  • Waste Connections undertakes no obligation to update the forward-looking statements set forth in this press release, whether as a result of new information, future events, or otherwise, unless required by applicable securities laws.

Waste Connections Announces Senior Notes Offering

Retrieved on: 
Tuesday, September 7, 2021

TORONTO, Sept. 7, 2021 /PRNewswire/ --Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") announced today that it plans to proceed, subject to market and other conditions, to offer two series of senior notes due 2032 and 2052, respectively (the "Notes"), in an underwritten public offering (the "Offering").

Key Points: 
  • TORONTO, Sept. 7, 2021 /PRNewswire/ --Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") announced today that it plans to proceed, subject to market and other conditions, to offer two series of senior notes due 2032 and 2052, respectively (the "Notes"), in an underwritten public offering (the "Offering").
  • Waste Connections intends to use the net proceeds from this offering, together with borrowings under its revolving credit facility provided under its credit agreement, to repay the $1.5 billion aggregate principal amount outstanding of each series of its senior notes issued pursuant to its master note purchase agreements.
  • Waste Connections is an integrated solid waste services company that provides non-hazardous waste collection, transfer and disposal services, along with resource recovery primarily through recycling and renewable fuels generation.
  • Waste Connections also provides non-hazardous oilfield waste treatment, recovery and disposal services in several basins across the U.S., as well as intermodal services for the movement of cargo and solid waste containers in the Pacific Northwest.

Waste Connections Announces Acquisition Of E.L. Harvey & Sons

Retrieved on: 
Wednesday, September 1, 2021
Industry, Company, Terminology, Municipal solid waste, Waste Connections, Acquisition, Movement, SEC, M. D. Moody & Sons, Inc., Private Securities Litigation Reform Act, Pacific Northwest, PSLRA, Forward-looking statement, Risk, Recycling, WCN, Culture, Harvey

TORONTO, Sept. 1, 2021 /PRNewswire/ --Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") today announced that it has acquired E.L. Harvey & Sons Inc. ("Harvey").

Key Points: 
  • TORONTO, Sept. 1, 2021 /PRNewswire/ --Waste Connections, Inc. (TSX/NYSE: WCN) ("Waste Connections" or the "Company") today announced that it has acquired E.L. Harvey & Sons Inc. ("Harvey").
  • With a 110-year history dating back four generations, Harvey is the largest family-owned and operated solid waste services company inMassachusetts,with total annualized revenue of approximately$110 million.
  • "The Harvey family has established one of the most respected companies in our industry, and we are honored to welcome Harvey to the Waste Connections family.
  • Waste Connections is an integrated solid waste services company that provides non-hazardous waste collection, transfer and disposal services, along with resource recovery primarily through recycling and renewable fuels generation.